4Miklos Z Molnar, Kamyar Kalantar-Zadeh, et al. ACE Inhibitor and Angiotensin Receptor Blocker Use and Mortality in Patients with Chronic Kidney DiseaseE J~. J Am Coil Cardiol, 2014, 63 (7) : 650-658.
4Volhard F, Fahr T. Die brightsche nierenkrankheit, Klinik, Pathologie und Atlas. 1 st ed. Berlin: Verlag yon Julius Springer, 1914 : 247-280.
5Jiang L, Zhang JJ, Lv JC, et al. Malignant hypertension in IgA nephropathy was not associated with background pathological phenotypes of glomerular lesions. Nephml Dial Transplant, 2008, 23 : 3921-3927.
6Gu DF,Reynolds K,Wu XG,et al.Prevalence,awareness,treatment,and control of hypertension in China[J].Hypertension,2002,40(6):920-927.
7Volpe M,Pagannone E,Tocci G,et al.Hypertension and heart failure:role of neurobormonal mechanisms[J].Clin Exp Hypertens,2004,26(7-8):603-610.
